Home
Pontifax Management 4 G.P., 10% Owner: Keros Therapeutics KROS Sell · Filed 25/10/17
Trade details
- Type
- Insider sale
- Amount
- $2,755,900.5
- Shares · price
- 155,262 sh · $17.75 a share
- Held after
- 0 sh
- Trade date
- 25/10/15
- Filed
- 25/10/17
- Days to filing
- 2 days
Sold 100.0% of holdings
- Share of holding sold
- 100.0%
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/15~25/11/14Pontifax Management 4 G.P.'s recent trades
- Pontifax Management 4 G.P.
SellKeros Therapeutics
SellKeros Therapeutics
KROS
$40.6M
2,284,612 sh
$40.6M
Filed 25/10/17
Traded 25/10/15
- Pontifax Management 4 G.P.
SellKeros Therapeutics
SellKeros Therapeutics
KROS
$21.8M
1,226,412 sh
$21.8M
Filed 25/10/17
Traded 25/10/15
- Pontifax Management 4 G.P.
SellKeros Therapeutics
SellKeros Therapeutics
KROS
$19.9M
1,121,045 sh
$19.9M
Filed 25/10/17
Traded 25/10/15
- Pontifax Management 4 G.P.
BuyLB Pharmaceuticals
BuyLB Pharmaceuticals
LBRX
$15M
1,000,000 sh
$15M
Filed 25/09/16
Traded 25/09/12
